Most transgenic mouse models of AD are designed to overexpress genes associated with early onset familial type of AD, such genes APP, PSEN-1, and PSEN-2 genes, and the mouse strains are characterized with the pathological deposition of Aβ peptide [181]. This evidence concerns the gene APP and Alzheimer disease.